Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera
- PMID: 18394554
- DOI: 10.1016/j.ccr.2008.02.009
"VSports手机版" Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera
V体育2025版 - Abstract
We report that TG101348, a selective small-molecule inhibitor of JAK2 with an in vitro IC50 of approximately 3 nM, shows therapeutic efficacy in a murine model of myeloproliferative disease induced by the JAK2V617F mutation VSports手机版. In treated animals, there was a statistically significant reduction in hematocrit and leukocyte count, a dose-dependent reduction/elimination of extramedullary hematopoiesis, and, at least in some instances, evidence for attenuation of myelofibrosis. There were no apparent toxicities and no effect on T cell number. In vivo responses were correlated with surrogate endpoints, including reduction/elimination of JAK2V617F disease burden assessed by quantitative genomic PCR, suppression of endogenous erythroid colony formation, and in vivo inhibition of JAK-STAT signal transduction as assessed by flow cytometric measurement of phosphorylated Stat5. .
Publication types
"VSports app下载" MeSH terms
- Actions (VSports最新版本)
- V体育官网入口 - Actions
- "VSports注册入口" Actions
- Actions (V体育官网入口)
- Actions (VSports在线直播)
- "V体育2025版" Actions
- "V体育安卓版" Actions
- V体育平台登录 - Actions
- VSports在线直播 - Actions
- "V体育官网入口" Actions
- Actions (VSports手机版)
Substances
- "VSports" Actions
- Actions (VSports在线直播)
- V体育安卓版 - Actions
- "V体育官网入口" Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
"V体育安卓版" Molecular Biology Databases
"V体育官网" Miscellaneous
